Artificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
In consumption market, the growth rate of global consumption is smooth relatively. North America is still the mainly consumption regions due to the advanced production technology and rapid development of economy.
We tend to believe this industry is a promising industry, and the consumption increasing degree will show a smooth growth curve. For product prices, the slow downward trend in recent years will maintain in the future as competition intensifies. Besides, prices gap between different brands will go narrowing gradually. Also, there will be fluctuation in gross margin.
According to this study, over the next five years the Artificial Tears market will register a 12.0% CAGR in terms of revenue, the global market size will reach US$ 3930 million by 2024, from US$ 2220 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Tears business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Tears market by product type, application, key manufacturers and key regions and countries.
This study considers the Artificial Tears value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Artificial Tear Liquid
Artificial Tear Ointment
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Dry Eyes Treatment
Contact Lenses Moisten
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Alcon (Novartis)
Bausch & Lomb
Abbott
Santen Pharmaceutical
Ursapharm
Rohto
Similasan Corporation
Johnson & Johnson
Ocusoft
Nicox
Sintong
Wuhan Yuanda
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Artificial Tears consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Artificial Tears market by identifying its various subsegments.
Focuses on the key global Artificial Tears manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artificial Tears with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artificial Tears submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
